The $1.8bn acquisition of Ally Bridge Group portfolio company ProfoundBio by Genmab is now complete. Congratulations to all stakeholders of ProfoundBio, in particular the three scientific co-founders Baiteng Zhao, Tae Han, Xiao Shang. Excited that your work will continue on in the capable hands of Genmab for the benefit of cancer patients. #venturecapital #biotech #innovation #medicine #healthcare
Ally Bridge Group
金融服务
New York，New York 1,307 位关注者
We focus on high-impact life science innovation addressing unmet medical needs.
关于我们
Ally Bridge Group is a global healthcare manager focused on high-impact life science innovation across private and public markets. Founded in 2013 by Frank Yu, Co-Chief Executive Officer and Co-Chief Investment Officer, the firm manages assets from offices in New York and Hong Kong. Our mission is to generate superior risk-adjusted returns for investors while seeking to address unmet medical needs. We aim to achieve this by blending deep scientific and clinical research with financial and capital markets expertise.
- 网站
-
https://www.ally-bridge.com
Ally Bridge Group的外部链接
- 所属行业
- 金融服务
- 规模
- 11-50 人
- 总部
- New York，New York
- 类型
- 私人持股
- 创立
- 2013
- 领域
- Healthcare